Weiss Multi Strategy Advisers LLC Travere Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

  • $0
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$15.3 - $22.61 $169,095 - $249,885
11,052 Added 6.08%
192,870 $2.96 Million
Q1 2023

May 15, 2023
BUY
$17.82 - $22.89 $566,996 - $728,314
31,818 Added 21.21%
181,818 $4.09 Million
Q4 2022

Feb 14, 2023
BUY
$18.47 - $26.14 $969,674 - $1.37 Million
52,500 Added 53.85%
150,000 $3.16 Million
Q3 2022

Nov 14, 2022
BUY
$22.91 - $28.63 $292,285 - $365,261
12,758 Added 15.06%
97,500 $2.4 Million
Q2 2022

Aug 15, 2022
BUY
$20.94 - $30.01 $1.77 Million - $2.54 Million
84,742 New
84,742 $2.05 Million

Others Institutions Holding TVTX

# of Institutions
214
Shares Held
94.3M
Call Options Held
1.2M
Put Options Held
778K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.32B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email